Viper
Device Spine
PDI 10705034132969
General payments
$2,662,655
Research payments
$81,805
Through program year 2025, $2,662,655 in general payments and $81,805 in research payments were reported against Viper (Spine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $184,639 | 248 |
| 2025 | Research | $22,200 | 2 |
| 2024 | General | $334,219 | 814 |
| 2024 | Research | $32,995 | 1 |
| 2023 | General | $406,965 | 789 |
| 2023 | Research | $4,095 | 1 |
| 2022 | General | $684,498 | 901 |
| 2021 | General | $1,052,334 | 1,168 |
| 2021 | Research | $22,515 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 36 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,920 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.